Reputation

J&J marketing triggers $2.2B payout

J&J marketing triggers $2.2B payout

By

The company will shell out $2.2 billion over allegations of marketing misconduct for Risperdal, Invega and Natrecor.

Business briefs: Quintiles and Forest, plus Paula Watch

Quintiles buys a CRO; Forest and Almirall delay their COPD combo drug; and Paula Deen may pop up on the Food Network Sunday

Business briefs: Medscape, Livestrong, ACA, Lilly

Medscape asked and doctors shared what they hate about most medical apps, Livestrong merch hits the clearance rack, healthcare reform savings begin to surface, Lilly releases early RA drug trial results

Armstrong brand has life beyond cycling, experts say

By

Lance Armstrong's story is about more than cycling. PR and brand experts weighed in on how they would safeguard his cancer foundation's reputation.

Docs trust ED drugs above all, go with their emotions when prescribing

Docs trust ED drugs above all, go with their emotions when prescribing

By

Viagra and Cialis took top honors for most trusted pharmaceutical brands in a poll of physicians.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.